SREK1IP1 is predicted to participate as a splicing regulator [29], because overexpression and knockdown of SRrp86, a SREK1IP1 interacting protein, resulted in the alternative splicing of various genes, such as c-Jun and IκBβ, in cancer cells [30]. The gene discussed is SREK1; the disease is cancer.